B Cell Maturation Antigen (BCMA) Targeted Therapies Market
B CELL MATURATION ANTIGEN (BCMA) TARGETED THERAPIES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
B-cell Maturation Antigen (BCMA) Targeted Therapies Market, by Product Type (CAR-T cell, Bispecific Antibodies, and Antibody Drug Conjugates), by Indication (Acute Lymphoblastic Leukemia, and Multiple Myeloma), and by Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
- Published In: 20 Oct, 2017
- Code: CMI190
- Page number: 130
- Formats: Excel and PDF
- Industry: Biotechnology
Table of Contents (Version-2026)
Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
- Market Snapshot
Market Dynamics, Opportunity, and Pipeline Analysis
- Market Dynamics
- Drivers
- Restraints
- Market opportunity
- Pipeline Analysis
- Targeted therapies developed till now
- Epidemiology
Global B-cell Maturation Antigen (BCMA) Targeted Therapies Market, By Product Type
- Introduction
- Antibody Drug Conjugates
- Research Details
- CAR- T cells
- Research Details
- Bispecific Antibodies
- Research Details
Global B-cell Maturation Antigen (BCMA) Targeted Therapies Market, By Indication
- Introduction
- Acute Lymphoblastic Leukemia
- Overview
- Multiple Myeloma
- Overview
Global B-cell Maturation Antigen (BCMA) Targeted Therapies Market, By Regions
- Introduction
- Addressable Market
- North America
- Overview
- Epidemiology
- Latin America
- Overview
- Epidemiology
- Europe
- Overview
- Epidemiology
- Asia Pacific
- Overview
- Epidemiology
- Middle East
- Overview
- Epidemiology
- Africa
- Overview
- Epidemiology
Company Profiles
- Celgene Corporation
*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Juno Therapeutics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Gilead Sciences. Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Amgen Inc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Affimed N.V
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Poseida Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Autolus Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us and Sales Contact
-
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
EXISTING CLIENTELE
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
